Non-MHC-restricted cell-mediated lysis of human oligodendrocytes in vitro: Relation with CD56 expression

Journal of Immunology

Volumn 160, Issue 4, 1998, Pages 1606-1611

  Antel, Jack P ^a   McCrea, Ellie ^a   Ladiwala, Uma ^a   Qin, Yu Fen ^a   Becher, Burkhard ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; MYELIN BASIC PROTEIN;

ANTIGEN EXPRESSION; ARTICLE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; CYTOTOXICITY TEST; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0032519963     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.160.4.1606     Document Type: Article

References (38)

1. Lucchinetti, C. F., W. Bruck, M. Rodriguez, and H. Lassman. 1996. Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol. 6:259.
2. Owens, T., and S. Sriram. 1995. The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis. Neurol. Clin. 13:51.
3. Wucherpfennig, K. W., and D. A. Hafler. 1995. A review of T cell receptors in multiple sclerosis: clonal expansion and persistence of human T-cells specific for an immunodominant myelin basic protein peptide. Ann. NY Acad. Sci. 756:241.
4. Allegretta, M., and L. Steinman. 1995. Unique T cell receptor junctional sequences found in multiple sclerosis and T cells mediating experimental allergic encephalomyelitis. Ann. NY Acad. Sci. 756:265.
5. + cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. J. Immunol. 148:1359.
6. + cytolytic T-lymphocyte clones isolated from multiple sclerosis patients. Hum. Immunol. 22:97.
7. Grenier, Y., T. C. G. Ruijs, Y. Robitaille, A. Olivier, and J. P. Antel. 1989. Immunohistochemical studies of adult human glial cells. J. Neuroimmunol. 21:103.
8. Lee, S. C., and C. S. Raine. 1989. Multiple sclerosis: oligodendrocytes in active lesions do not express class II major histocompatility complex molecules. J. Neuroimmunol. 25:261.
9. + myelin-reactive T cells lyses target cells expressing CD56/neural cell adhesion molecule. J. Immunol. 157:679.
10. Lanier, L. L., A. M. Le, C. I. Civan, M. R. Loken, and J. H. Phillips. 1986. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human blood NK cells and cytotoxic T lymphocytes. J. Immunol. 136:4480.
11. + cells derived from T cells with potent in vivo antitumour activity in mice with severe combined immunodeficiency. J. Immunol. 153:1687.
12. + surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with hepatitis B virus. J. Immunol. 152:3074.
13. Satoh, J., S. U. Kim, and L. F. Kastrukoff. 1990. Absence of natural killer (NK) cell activity against oligodendrocytes in multiple sclerosis. J. Neuroimmunol. 26:75.
14. Satoh, J.-i., S. U. Kim, and L. F. Kastrukoff. 1991 Lymphokine-activated killer (LAK) and adherent LAK (A-LAK) activity in multiple sclerosis. J. Neuroimmunol. 32:111.
15. Lanier, L. L., R. Testi, J. Bindl, and J. H. Phillips,. 1989. Identity of Leu-19 (CD56) leukocyte differentiation marker and neural cell adhesion molecule. J. Exp. Med. 169:2233.
16. Cross, A. H., T. O'Mara, C. S. Raine. 1993. Chronologic localization of myelin-reactive cells in the lesions of relapsing EAE: implications for the study of multiple sclerosis. Neurology 43:1028.
17. Oksaranta, O., S. Tarvonen, J. Ilonen, K. Poikonen, M. Reunanen, M. Panelius, and R. Salonen. 1995. Influx of nonactivated T lymphocytes into the cerebrospinal fluid during relapse of multiple sclerosis. Ann. Neurol. 38:465.
18. + T cells independent of tumour necrosis factor. Ann. Neurol. 35:341.
19. Chou, F. C. H., J. C. H. Chou, R. Shapira, and R. F. Kibler. 1976. Basis of micro-heterogeneity of myelin basic protein. J. Biol. Chem. 251:2671.
20. Yong, V. W., and J. P. Antel. 1992. Culture of glial cells from human brain biopsies. In Protocols for Neural Cell Culture. S. Fedoroff and A. Richardson, eds. Humana Press, New York, pp. 81-96.
21. Williams, N., P. Dooley, E. Ulvestad, A. Waage, M. Blain, V. W. Yong, and J. P. Antel. 1995. Antigen presentation by human fetal astrocytes with the cooperative effect of microglia or the microglial-derived cytokine IL-1. J. Neurosci. 15:1869.
22. Kataoka, T., N. Shinohara, H., K. Takaku, S. Kondo, S. Yonehara, and K. Nagai. 1996. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. J. Immunol. 156:3678.
23. Jurewicz, W., E. Biddison, and J. P. Antel. 1997. MHC class 1 restricted killing of human oligodendrocytes by myelin basic protein peptide specific CD8 T lymphocytes. Neurology 48:A381.
24. Satoh, J.-I., L. F. Kastrukoff, and S. U. Kim. 1991. Cytokine-induced expression of intercellular adhesion molecule-1 (ICAM-1) in cultured human oligodendrocytes and astrocytes. J. Neuropathol. Exp. Neurol. 50:215.
25. D'Souza, S. D., K. A. Alinauskas, E. McRae, C. Goodyer, and J. P. Antel. 1995. Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury. J. Neurosci. 15:7293.
26. Selmaj, K., C. S. Raine, M. Farooq, W. T. Norton, and C. F. Brosnan. 1991. Cytokine cytotoxicity against oligodendrocytes: apoptosis induced by lymphotoxin. J. Immunol. 147:1522.
27. Wilt, S. G., E. Milward, J. M. Zhou, K. Nagasato, H. Patton, R. Rusten, D. E. Griffin, M. O'Conner, and M. Dubois-Dalq. 1995. In vitro evidence for a dual role of tumor necrosis factor a in human immunodeficiency virus type 1 encephalopathy. Ann. Neurol. 37:381.
28. D'Souza, S. D., B. Bonetti, V. Balasingam, N. R. Cashman, P. A. Barker, A. B. Troutt, C. S. Raine, and J. P. Antel. 1996. Multiple sclerosis: Fas signalling in oligodendrocyte cell death. J. Exp. Med. 184:2361.
29. Freedman, M. S., T. C. G. Ruijs, L. K. Selin, and J. P. Antel. 1991. Peripheral blood gd cells lyse fresh human brain-derived oligodendrocytes. Ann. Neurol. 30:794.
30. Zeine, R., R. Pon, L. G. Filion, and M. Freedman. 1996. Mechanism of γδ T cell cytotoxicity in multiple sclerosis. Ann. Neurol. 40:555.
31. Kagi, D., F. Vignaux, K. Burki, V. Depraetere, S. Nagata, H. Hengartener, and P. Golstein. 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528.
32. Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370:650.
33. + T cell-mediated cytotoxicity. J. Immunol. 152:1127.
34. + CTL that utilizes a perforin rather that Fas ligand-dependent cytotoxic mechanism. J. Immunol. 156:153.
35. Scolding, N. J., J. Jones, D. A. S. Compston, and B. P. Morgan. 1990. Oligodendrocyte susceptibility to injury by T cell perforin. Immunology 70:6.
36. + T cell clones use perforin-or FAS ligand-mediated pathways for target cells. J. Immunol. In press.
37. Link, J., M. Soderstrom, T. Olsson, B. Hojeberg, A. Ljungdahl, and H. Link. 1994. Increased transforming growth factor β, interleukin 4 and Interferon γ in multiple sclerosis activated T cells. Ann. Neurol. 36:379.
38. Hoffman, F. M., R. I. von Hanwehr, C. A. Dinarello, S. B. Mizel, D. Hinton, and J. E. Merrill. 1986. Immmunoregulatory molecules and IL-2 receptors identified in multiple sclerosis brain. J. Immunol. 136:3239.